Dejan Micic to Middle Aged
This is a "connection" page, showing publications Dejan Micic has written about Middle Aged.
Connection Strength
0.506
-
Predictive Model for Positive Video Capsule Endoscopy in Iron Deficiency Anemia. Dig Dis Sci. 2023 07; 68(7):3083-3091.
Score: 0.060
-
Impact of Early Video Capsule Endoscopy on Hospitalization and Post-hospitalization Outcomes: A Propensity Score-Matching Analysis. Dig Dis Sci. 2022 08; 67(8):3584-3591.
Score: 0.054
-
Hiding in the Water. N Engl J Med. 2020 May 07; 382(19):1844-1849.
Score: 0.049
-
Getting to the Root of the Problem. Gastroenterology. 2020 04; 158(5):1229-1231.
Score: 0.047
-
Risk factors for small bowel bleeding in an overt gastrointestinal bleeding presentation after negative upper and lower endoscopy. PLoS One. 2019; 14(2):e0212509.
Score: 0.045
-
Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective Study. Dig Dis Sci. 2018 04; 63(4):1016-1024.
Score: 0.042
-
Factors associated with readmission to the hospital within 30 days in patients with inflammatory bowel disease. PLoS One. 2017; 12(8):e0182900.
Score: 0.041
-
Older Age at First Screening Colonoscopy is Associated With an Increased Risk of Colorectal Adenomas and Cancer. J Clin Gastroenterol. 2023 09 01; 57(8):804-809.
Score: 0.015
-
Outcome of elective switching to vedolizumab in inflammatory bowel disease patients under tumor necrosis factor antagonist-maintained clinical remission. J Gastroenterol Hepatol. 2019 Dec; 34(12):2090-2095.
Score: 0.012
-
Risk Factors for 30-day Hospital Readmission for Diverticular Hemorrhage. J Clin Gastroenterol. 2019 04; 53(4):e133-e141.
Score: 0.011
-
Risk of gastrointestinal cancers in patients with cystic fibrosis: a systematic review and meta-analysis. Lancet Oncol. 2018 06; 19(6):758-767.
Score: 0.011
-
Vedolizumab as Induction and Maintenance for Inflammatory Bowel Disease: 12-month Effectiveness and Safety. Inflamm Bowel Dis. 2018 03 19; 24(4):849-860.
Score: 0.011
-
Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease. Aliment Pharmacol Ther. 2018 Mar; 47(6):753-762.
Score: 0.010
-
Meta-Analysis of the Risk of Immune-Related Adverse Events With Anticytotoxic T-Lymphocyte-Associated Antigen 4 and Antiprogrammed Death 1 Therapies. Clin Pharmacol Ther. 2018 02; 103(2):318-331.
Score: 0.010
-
Autoimmune gastrointestinal dysmotility due to small cell lung cancer. BMJ Case Rep. 2017 Aug 11; 2017.
Score: 0.010
-
The benefit of paracentesis on hospitalized adults with cirrhosis and ascites. J Gastroenterol Hepatol. 2016 May; 31(5):1025-30.
Score: 0.009
-
Hematochezia and a Mesenteric Mass. Gastroenterology. 2015 Jul; 149(1):e12-3.
Score: 0.009
-
Clostridium difficile ribotype 027: relationship to age, detectability of toxins A or B in stool with rapid testing, severe infection, and mortality. Clin Infect Dis. 2015 Jul 15; 61(2):233-41.
Score: 0.009
-
Patchy colitis and interstitial lung disease. Gastroenterology. 2015 Jan; 148(1):26-7.
Score: 0.008
-
In vitro sensitivity assays and clinical response to glucocorticoids in patients with inflammatory bowel disease. J Crohns Colitis. 2014 Nov; 8(11):1539-47.
Score: 0.008
-
The systemic inflammatory response to Clostridium difficile infection. PLoS One. 2014; 9(3):e92578.
Score: 0.008
-
Storage duration of red blood cell transfusion and Clostridium difficile infection: a within person comparison. PLoS One. 2014; 9(2):e89332.
Score: 0.008
-
Procalcitonin levels associate with severity of Clostridium difficile infection. PLoS One. 2013; 8(3):e58265.
Score: 0.007
-
Clostridium difficile ribotype does not predict severe infection. Clin Infect Dis. 2012 Dec; 55(12):1661-8.
Score: 0.007
-
[Diverticulosis of the digestive tract in our patients over a 10-year period]. Zb Vojnomed Akad. 1981; 23:42-5.
Score: 0.003